KUKJEON PHARMACEUTICAL Co., Ltd (KOSDAQ: 307750)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,810.00
+75.00 (2.01%)
Nov 18, 2024, 9:00 AM KST

KUKJEON PHARMACEUTICAL Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21
Market Capitalization
186,953306,192324,839537,308
Market Cap Growth
-13.53%-5.74%-39.54%-
Enterprise Value
193,032319,290284,635-
Last Close Price
3810.006240.006609.1510932.05
PE Ratio
58.4463.67582.25120.13
PS Ratio
1.402.513.136.30
PB Ratio
1.883.143.526.46
P/TBV Ratio
2.533.223.606.49
P/OCF Ratio
29.51--176.63
EV/Sales Ratio
1.452.622.74-
EV/EBITDA Ratio
24.7333.1157.72-
EV/EBIT Ratio
60.3549.0581.60-
Debt / Equity Ratio
0.740.810.640.09
Debt / EBITDA Ratio
9.538.1712.031.09
Asset Turnover
0.620.580.68-
Inventory Turnover
4.004.054.62-
Quick Ratio
0.910.941.672.72
Current Ratio
1.201.242.023.52
Return on Equity (ROE)
4.77%4.94%10.12%-
Return on Assets (ROA)
0.92%1.93%1.44%-
Return on Capital (ROIC)
1.19%2.48%1.80%-
Earnings Yield
1.71%1.58%2.75%0.75%
FCF Yield
-4.45%-14.46%-9.02%-1.37%
Dividend Yield
0.27%0.16%--
Payout Ratio
9.16%-5.48%-
Buyback Yield / Dilution
-5.99%4.23%-16.16%-
Total Shareholder Return
-5.72%4.39%-16.16%-
Source: S&P Capital IQ. Standard template. Financial Sources.